Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,206 35,275
2023-02-14 Wolff Stefani EVP and COO Grant or award · Employee Stock Option (right to buy) +88,900 88,900
2023-02-14 Wolff Stefani EVP and COO Grant or award · Restricted Stock Units +24,000 24,000
2023-02-14 van Houte Hans Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +88,900 88,900
2023-02-14 van Houte Hans Chief Financial Officer Grant or award · Restricted Stock Units +24,000 24,000
2023-02-14 SANDS ARTHUR T President, CEO Grant or award · Employee Stock Option (right to buy) +448,000 448,000
2023-02-14 Ring Christine General Counsel Grant or award · Employee Stock Option (right to buy) +88,900 88,900
2023-02-14 Ring Christine General Counsel Grant or award · Restricted Stock Units +24,000 24,000
2023-02-14 Hansen Gwenn Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +88,900 88,900
2023-02-14 Hansen Gwenn Chief Scientific Officer Grant or award · Restricted Stock Units +24,000 24,000
2023-01-30 Wolff Stefani EVP and COO Option exercise +962 4,364
2023-01-30 Wolff Stefani EVP and COO Sale −424 $11.78 $5K 3,940
2023-01-30 Wolff Stefani EVP and COO Option exercise · Restricted Stock Units −962 11,544
2023-01-30 van Houte Hans Chief Financial Officer Option exercise +2,886 77,689
2023-01-30 van Houte Hans Chief Financial Officer Sale −924 $11.78 $11K 76,765
2023-01-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 34,633
2023-01-30 Ring Christine General Counsel Option exercise +1,924 8,109
2023-01-30 Ring Christine General Counsel Sale −848 $11.78 $10K 7,261
2023-01-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 23,089
2023-01-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 24,421

Page 26 of 32 · 632 trades